This website is here to provide answers to men regarding radiation therapy for the treatment of their prostate cancer. Over many years treating men for prostate cancer, I’ve noticed the same questions coming up over and over, so I thought I would put all the answers in one place!
I hope that this website will answer your questions about basic information regarding cancer and radiation, finding out what stage the cancer is, choosing between the different treatments, learning how we plan and schedule radiation therapy and the actual treatment process, managing side effects, and monitoring the cancer afterwards. This website is not meant to substitute for your own doctor’s advice. Every person and treatment combination is different and your specific situation may require different advice. As well, different doctors have different philosophies and approaches to a prostate cancer diagnosis. This is my own personal website, and it is not officially connected with the cancer centers I work at.
Consultation and Contact Information
If you would like a consultation with myself, Dr. Doug Kelly, please make an appointment at Hillcrest Medical Center in Tulsa, OK. I may also be able to answer some e-mail questions.
keywords: prostrate postate CaP PCa CAP PC adenocarcinoma adeno carcinoma cancre tumor lump stage 1 2 3 4 radiation therapy rads xrt radiotherapy radiotherpy radiation radiate radium radioactive nonsurgical non-surgical avoid surgery cobalt IMRT intensity modulated IGRT image guided 3D conformal proton cyberknife robotic surgery prostatectomy cryotherapy HDR high dise rate brachytherapy permanent seed implant temporary seeding treatment treat options staging diagnosis testing scans scanning management Dr.Kelly Douglas A. Kelly MD Kelley M.D. doctor CTCA cancer treatment centers of america board certified radiation oncologist oncology radonc Tulsa OK Oklahoma USA best top cure rate where should I go top experts options advice second opinions http://www.brachytherapy.com http://www.zeropsa.com http://www.aowoc.com http://www.cancercenter.com low intermediate high risk